views - 128
<p>A booster shot of the anti-Covid-19 vaccine developed by Pfizer/BioNTech is 95.6 per cent effective against symptomatic infection, according to trial data published by the makers on Thursday.</p>
Click here to view full article source
Current Page - 1 out of 1